Lupin Limited has informed the Exchange regarding a press release dated December 21, 2020, titled "Lupin Receives Approval for Rufinamide Oral Suspension.".
Lupin Limited has informed the Exchange regarding a press release dated December 21, 2020, titled "Lupin Receives Approval for Rufinamide Oral Suspension.".